13 October 2020 - record interim results
LiDCO, the AIM-listed hemodynamic monitoring group has announced record interim results for the six months to 31 July. Revenues increased by 75% to £6.2m (2019: £3.5m) whilst the group recorded an adjusted pre-tax profit of £1.2m (2019: loss of £0.8m). Earnings per share emerged at 0.56p and strong cashflow resulted in net cash balances of £3.1m at the end of the period. Increased demand for the group's products due to Covid-19 led to the sale of 230 monitors during the period (2019: 111 monitors . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters. Get one week FREE trial with all our packages. Registration is quick and simple HERE.
Already a member, log in HERE.